RAB5B and nasopharyngeal carcinoma: Specifically, the suppression of invasion and metastasis of breast cancer stem cell-like cells by miR-130a-3p was achieved through targeting RAB5B [12], and the inhibition of proliferation, invasion, and metastasis of nasopharyngeal carcinoma (NPC) cells by this miRNA was achieved by inhibiting the expression of BACH2 [13] and CXCL12 [14].